Bevacizumab and confusional state Patient Reports February 10, 2012

Bevacizumab Side Effects Report #4729969-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 15, 2005. Female patient, 79 years of age, weighting 140.0 lb, was diagnosed with peritoneal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, body temperature increased, cerebral ischaemia, chills, cholelithiasis, cognitive disorder, confusional state, disorientation. Bevacizumab dosage: 925 MG,Q3W, INTRAVENOUS. During the same period patient was treated with LORTAB, ATIVAN, AMITRIPTYLINE, SUDAFED, FIORICET, PREVACID, BABY ASPIRN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5782559-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 09, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, hypertension, nausea

. Bevacizumab dosage: 387 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, ATORVASTATIN, BENDROFLUAZIDE, CALCICHEW, CITALOPRAM HYDROBROMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5911508-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 23, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, hypertension, nausea

. Bevacizumab dosage: 387 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, ATORVASTATIN, BENDROFLUAZIDE, CALCICHEW, CITALOPRAM HYDROBROMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5985129-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 26, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, hypertension, nausea

. Bevacizumab dosage: 387 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, ATORVASTATIN CALCIUM, BENDROFLUAZIDE, CALCICHEW, CITALOPRAM HYDROBROMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5277917-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 12, 2007. Male patient, 68 years of age, weighting 160.7 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, leukoencephalopathy. Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, CAROBPLATIN. Patient died on 03/09/2007.

Bevacizumab Side Effects Report #5287051-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 68 years of age, weighting 160.7 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arteriosclerosis, asthenia, bacteria urine identified, blood glucose increased, cerebrovascular disorder, confusional state, depressed level of consciousness, drooling, leukoencephalopathy. Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, LOVASTATIN, ATENOLOL, LISINOPRIL, ASPIRIN. Patient was hospitalized. Patient died on 03/09/2007.

Bevacizumab Side Effects Report #4967125-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2006. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis, blood pressure increased, confusional state, convulsion, hypertension, hypertensive encephalopathy, hypokalaemia, malignant neoplasm progression. Bevacizumab dosage: unknown. During the same period patient was treated with PACILTAXEL, ACETAMINOPHEN, LABETALOL, ROCEPHIN, TOPROL, LISINOPRIL, AMPICILLIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5660676-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 03, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: unknown. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5689220-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 24, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 960 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMZAR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5717778-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 17, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blepharitis, blood albumin decreased, confusional state, haemoglobin decreased, hypocalcaemia, hypokalaemia, platelet count decreased. Bevacizumab dosage: 960 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMZAR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5725388-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 24, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 960 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMZAR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5760106-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 22, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, dehydration, hypotension. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GLYBURIDE, METFORMIN, DIAZEPAM, LIPITOR, DILAUDID, MONOCOR, HYSRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5789453-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 13, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 15 MG, Q3W. Patient recovered.

Bevacizumab Side Effects Report #5800823-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 27, 2008. Male patient, weighting 158.7 lb, was diagnosed with non-small cell lung cancer, pain

, constipation

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 1240 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FENTANYL, MOTRIN, MIRALAX. Patient recovered.

Bevacizumab Side Effects Report #5819587-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 15, 2008. Male patient, weighting 158.7 lb, was diagnosed with non-small cell lung cancer, pain

, constipation

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, hallucination. Bevacizumab dosage: 1240 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FENTANYL, MOTRIN, MIRALAX. Patient recovered.

Bevacizumab Side Effects Report #5880293-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 05, 2008. Male patient, weighting 128.0 lb, was diagnosed with non-small cell lung cancer, metastases to central nervous system, convulsion and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood glucose increased, blood potassium decreased, brain oedema, carotid artery stenosis, cerebellar infarction, cerebral haemorrhage, confusional state, convulsion. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, COMBIVENT, DILANTIN, PHENOBARBITAL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5917974-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 15 MG, Q3W. During the same period patient was treated with ATIVAN, LYRICA, DILAUDID, BISACODYL, FRAGMIN, COLACE, FENTANYL, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5975295-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 21, 2008. Female patient, weighting 89.98 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cerebral atrophy, confusional state, encephalopathy, hypertension. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with PEMETREXED, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6086361-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 12, 2009. Female patient, weighting 119.0 lb, was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 398 MG, Q21D. During the same period patient was treated with PROTONIX, ALDACTONE, LASIX, FOLIC ACID, ACTIGALL, CREON, PREDNISONE, ATENOLOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6045905-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 13, 2009. Male patient, 68 years of age, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, lymphopenia, pneumonia

. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5416591-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 03, 2007. Female patient, weighting 125.7 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, encephalopathy. Bevacizumab dosage: 290 MG, Q2W. During the same period patient was treated with BETALOC, NIFEDIPINE, INDOMETHACIN, GLUTATHIONE, FAMOTIDINE, CAPTOPRIL, ATENOLOL. Patient was hospitalized. Patient died on 04/02/2007.

Bevacizumab Side Effects Report #5852710-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 18, 2008. Male patient was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5884383-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 09, 2008. Male patient was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5886888-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 02, 2008. Male patient was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ataxia

, confusional state, disease progression, muscular weakness, nuclear magnetic resonance imaging brain abnormal. Bevacizumab dosage: 15 MG/KG, Q14D. During the same period patient was treated with INTRON A, INTRON A. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4897413-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 30, 2006. Female patient, weighting 114.6 lb, was diagnosed with metastasis, transitional cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, dysarthria, fatigue, foaming at mouth, grand mal convulsion, headache

, hypertensive encephalopathy, loss of consciousness. Bevacizumab dosage: 15MG/KG -806MG, 834MG, 780MG ONCE EVERY 3 WEEKS IV DRIP. Patient recovered.

Bevacizumab Side Effects Report #5921260-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2008. Female patient was diagnosed with malignant melanoma, metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, disease progression, muscular weakness. Bevacizumab dosage: 15 MG/KG, Q14D. During the same period patient was treated with INTERFERON ALFA, INTERFERON ALFA. Patient recovered.

Bevacizumab Side Effects Report #4699481-8
Bevacizumab side effect was reported by a Physician from on June 23, 2005. Female patient, 52 years of age, weighting 262.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chills, confusional state, dyspnoea, lung infiltration, productive cough, pyrexia, sputum discoloured, vomiting. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, FENTANYL, REGLAN, OXYCODONE, LANTUS, GLUCOPHAGE, GLYBURIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4705470-7
Bevacizumab side effect was reported by a Physician from on June 30, 2005. Female patient, 52 years of age, weighting 202.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chills, confusional state, dyspnoea, productive cough, pyrexia, respiratory failure, vomiting. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, FENTANYL, REGLAN, OXYCODONE, LANTUS, GLUCOPHAGE, GLYBURIDE. Patient was hospitalized. Patient died on 06/29/2005.

Bevacizumab Side Effects Report #4726142-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 25, 2005. Female patient, 52 years of age, weighting 202.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, lung infiltration, productive cough, pyrexia, respiratory failure, vomiting. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, FENTANYL, REGLAN, OXYCODONE, LANTUS, GLUCOPHAGE, GLYBURIDE. Patient was hospitalized. Patient died on 06/29/2005.

Bevacizumab Side Effects Report #5265812-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, 68 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, haematochezia, haemoglobin decreased, mental status changes, neuropathy, oral intake reduced, prothrombin time abnormal, sedation. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, TIMOLOL MALEATE, NEXIUM, COUMADIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5572215-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 17, 2007. Male patient, 44 years of age, weighting 172.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with KEPPRA, TEMOZOLOMIDE, STEROIDS, PAXIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5593773-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 08, 2008. Male patient, 44 years of age, weighting 172.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: brain oedema, confusional state, nuclear magnetic resonance imaging brain abnormal, somnolence. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with KEPPRA, TEMOZOLOMIDE, STEROIDS, PAXIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5366334-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 41 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia

, confusional state, convulsion, headache

, herpes simplex

, muscular weakness, nuclear magnetic resonance imaging brain abnormal, vision blurred. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, PAXIL, PROTONIX, DEXAMETHASONE, DILANTIN, LIPITOR, AMBIEN, ZITHROMAX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5329901-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Female patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, disease progression, haemorrhage, headache

, hypoaesthesia, no therapeutic response. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, NORVASC, DEXAMETHASONE, PEPCID, DILANTIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5332315-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Female patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, disease progression, haemorrhage, headache

, hypoaesthesia. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, NORVASC, DEXAMETHASONE, PEPCID, DILANTIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5878526-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2008. Male patient, weighting 195.6 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspergillosis, confusional state, wound infection. Bevacizumab dosage: 10 MG/KG, QD. During the same period patient was treated with TEMOZOLOMIDE, IRINOTECAN, ATIVAN, LIPITOR, LOPRESSOR, MAXIPIME, NEXIUM, PERCOCET. Patient died on 07/18/2008.

Bevacizumab Side Effects Report #5808454-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 10, 2008. Male patient, 50 years of age, weighting 196.2 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: amnesia, atelectasis, bacteria urine identified, chills, confusional state, convulsion, fall

, lung infiltration, nausea

. Bevacizumab dosage: unknown. During the same period patient was treated with BORTEZOMIB, OMNICEF, MS CONTIN, VICODIN, DILANTIN, DECADRON, ZESTRIL, NEXIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5485998-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2007. Male patient was diagnosed with diffuse large b-cell lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, dysphagia, fatigue, muscular weakness, neuropathy, neutrophil count decreased, white blood cell count decreased. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5485999-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2007. Male patient was diagnosed with diffuse large b-cell lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, dysphagia, faecal incontinence, fatigue, lethargy, lymphoma

, malaise, muscular weakness. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5379351-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 22, 2007. Female patient, weighting 128.3 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, DECADRON, BENADRYL, ONDANSETRON, ACETAMINOPHEN. Patient recovered.

Bevacizumab Side Effects Report #5405364-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 24, 2007. Male patient, weighting 195.6 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aggression, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood sodium decreased, blood urea increased, carbon dioxide decreased, confusional state, haematocrit decreased. Bevacizumab dosage: 667 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FLUOXETINE, SEROQUEL, MORPHINE SULPHATE, COMPAZINE, ANZEMET, OXYCODONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5875667-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 27, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5328032-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 17, 2007. Male patient, weighting 171.7 lb, was diagnosed with colorectal cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, dysphagia, pulmonary embolism

. Bevacizumab dosage: 390 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, PARACETAMOL, SEVREDOL, SENNA, MAXOLON, LACTULOSE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5955405-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with colorectal cancer

, colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, pneumonia

, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5325441-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 01, 2007. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation

, confusional state, hyperglycaemia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5306461-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 19, 2007. Female patient, weighting 163.1 lb, was diagnosed with bladder cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5328509-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 17, 2007. Female patient, weighting 163.1 lb, was diagnosed with bladder cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5345771-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 24, 2007. Female patient, weighting 163.1 lb, was diagnosed with bladder cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: accelerated hypertension, confusional state, demyelination, encephalopathy, urinary tract infection

. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6056018-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 13, 2009. Female patient was diagnosed with anaemia, prostate cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with GEMCITABINE, CISPLATIN, HYDROCHLOROTHIAZIDE, METFORMIN, ENALAPRIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5304458-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Male patient, 64 years of age, weighting 189.6 lb, was diagnosed with adenocarcinoma pancreas and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ERLOTINIB, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5327395-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 01, 2007. Female patient was diagnosed with adenocarcinoma pancreas and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, headache

, hypertension. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with CETUXIMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5929315-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 13, 2008. Male patient was diagnosed with acute myeloid leukaemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, arthritis

, confusional state, febrile neutropenia, fungal infection

, monoparesis, pleuritic pain. Bevacizumab dosage: unknown. During the same period patient was treated with DAUNORUBICIN, CYTARABINE, VANCOMYCIN. Patient recovered.

Bevacizumab Side Effects Report #5354526-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 01, 2007. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure congestive, confusional state, congestive cardiomyopathy, disorientation, ejection fraction decreased, fall

, left ventricular dysfunction, muscular weakness. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with INTRON A. Patient was hospitalized. Patient died on 04/21/2007.

Bevacizumab Side Effects Report #5376077-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2007. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia

, bronchitis

, candidiasis, confusional state, disease progression, fall

, fatigue, loss of consciousness, muscular weakness. Bevacizumab dosage: unknown. During the same period patient was treated with ETOPOSIDE, DIOVAN, SINGULAIR, PERCO, NEXIUM, FLONASE, DEXAMETHASONE, DYNACIRC. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5376078-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2007. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, aphasia

, confusional state, glioblastoma multiforme, hyponatraemia, malignant neoplasm progression, muscular weakness, partial seizures, therapeutic response decreased. Bevacizumab dosage: unknown. During the same period patient was treated with ETOPOSIDE, DIOVAN, SINGULAIR, PERCO, NEXIUM, FLONASE, DEXAMETHASONE, DYNACIRC. Patient was hospitalized. Patient recovered.

Bevacizumab and confusional state

SideEffects101.com

Bevacizumab and confusional state Patient Reports February 10, 2012

side effects of Bevacizumab